Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate. [electronic resource]
Producer: 20160629Description: 385-90 p. digitalISSN:- 1473-1150
- Alleles
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Methotrexate -- administration & dosage
- Methylenetetrahydrofolate Reductase (NADPH2) -- genetics
- Osteosarcoma -- drug therapy
- Polymorphism, Single Nucleotide
- Replication Protein C -- genetics
- Tetrahydrofolate Dehydrogenase -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.